Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasperini

Showing results (411-420 of 981) with videos related to

Pageof 99
Sort By:
Frontiers in Endocrinology|January 30, 2020
Aging and Imaging Assessment of Body Composition: From Fat to FactsFederico Ponti, Aurelia Santoro, Daniele Mercatelli, et al.
Neuron|October 8, 2013
Plasticity of recurrent l2/3 inhibition and gamma oscillations by whisker experienceYu R Shao, Brian R Isett, Toshio Miyashita, et al.
Frontiers in Neurology|December 17, 2020
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple SclerosisAntonio Giorgio, Marco Battaglini, Giordano Gentile, et al.
Therapeutic Advances in Neurological Disorders|May 23, 2022
Efficacy of prolonged-release fampridine <i>versus</i> placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCERaymond Hupperts, Claudio Gasperini, Jan Lycke, et al.
Eclinicalmedicine|January 31, 2024
Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trialRossana Sanchez Russo, Serena Gasperini, Gillian Bubb, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Journal of the American Medical Directors Association|December 11, 2012
Prevalence and potentially reversible factors associated with anorexia among older nursing home residents: results from the ULISSE projectFrancesco Landi, Fabrizia Lattanzio, Giuseppina Dell'Aquila, et al.
Glycobiology|December 22, 2018
Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylationRossella Indellicato, Rossella Parini, Ruben Domenighini, et al.
BMC Neurology|October 15, 2009
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective studyEmilia Sbardella, Valentina Tomassini, Claudio Gasperini, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
Pageof 99

Showing results (411-420 of 981) with videos related to

Sort By:
Pageof 99
Frontiers in Endocrinology|January 30, 2020
Aging and Imaging Assessment of Body Composition: From Fat to FactsFederico Ponti, Aurelia Santoro, Daniele Mercatelli, et al.
Neuron|October 8, 2013
Plasticity of recurrent l2/3 inhibition and gamma oscillations by whisker experienceYu R Shao, Brian R Isett, Toshio Miyashita, et al.
Frontiers in Neurology|December 17, 2020
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple SclerosisAntonio Giorgio, Marco Battaglini, Giordano Gentile, et al.
Therapeutic Advances in Neurological Disorders|May 23, 2022
Efficacy of prolonged-release fampridine <i>versus</i> placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCERaymond Hupperts, Claudio Gasperini, Jan Lycke, et al.
Eclinicalmedicine|January 31, 2024
Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trialRossana Sanchez Russo, Serena Gasperini, Gillian Bubb, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Journal of the American Medical Directors Association|December 11, 2012
Prevalence and potentially reversible factors associated with anorexia among older nursing home residents: results from the ULISSE projectFrancesco Landi, Fabrizia Lattanzio, Giuseppina Dell'Aquila, et al.
Glycobiology|December 22, 2018
Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylationRossella Indellicato, Rossella Parini, Ruben Domenighini, et al.
BMC Neurology|October 15, 2009
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective studyEmilia Sbardella, Valentina Tomassini, Claudio Gasperini, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
Pageof 99